To confirm that the cells in the tumor expressing endoglin are indeed epithelial cancer cells and not macrophages, which were also shown to express endoglin (44), we performed imaging mass spectrometry for each tumor type (Hyperion) with a six marker panel (pan-cytokeratin, endoglin, vimentin, CD45, CD68, and p53). The gene discussed is CD68; the disease is neoplasm.